Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

199 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bortezomib with chemotherapy is highly active in advanced B-precursor acute lymphoblastic leukemia: Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study.
Messinger YH, Gaynon PS, Sposto R, van der Giessen J, Eckroth E, Malvar J, Bostrom BC; Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Consortium. Messinger YH, et al. Among authors: van der giessen j. Blood. 2012 Jul 12;120(2):285-90. doi: 10.1182/blood-2012-04-418640. Epub 2012 May 31. Blood. 2012. PMID: 22653976 Free article. Clinical Trial.
Phase I study of bortezomib combined with chemotherapy in children with relapsed childhood acute lymphoblastic leukemia (ALL): a report from the therapeutic advances in childhood leukemia (TACL) consortium.
Messinger Y, Gaynon P, Raetz E, Hutchinson R, Dubois S, Glade-Bender J, Sposto R, van der Giessen J, Eckroth E, Bostrom BC. Messinger Y, et al. Among authors: van der giessen j. Pediatr Blood Cancer. 2010 Aug;55(2):254-9. doi: 10.1002/pbc.22456. Pediatr Blood Cancer. 2010. PMID: 20582937 Free article. Clinical Trial.
In vitro assay to determine inactivation of Toxoplasma gondii in meat samples.
Opsteegh M, Cuperus T, van Buuren C, Dam-Deisz C, van Solt-Smits C, Verhaegen B, Joeres M, Schares G, Koudela B, Egberts F, Verkleij T, van der Giessen J, Wisselink HJ. Opsteegh M, et al. Among authors: van der giessen j. Int J Food Microbiol. 2024 May 2;416:110643. doi: 10.1016/j.ijfoodmicro.2024.110643. Epub 2024 Mar 2. Int J Food Microbiol. 2024. PMID: 38452660 Free article.
Zoönosen, de publieke gezondheid en de huisarts.
Dusseldorp F, van der Giessen J, Opsteegh M, Loohuis AO, van der Ark K, Feenstra S, Havermans J. Dusseldorp F, et al. Among authors: van der giessen j. Huisarts Wet. 2023;66(6):36-39. doi: 10.1007/s12445-023-2265-0. Epub 2023 May 24. Huisarts Wet. 2023. PMID: 37252432 Free PMC article. Dutch.
Risk factors for acute toxoplasmosis in the Netherlands.
Friesema IHM, Hofhuis A, Hoek-van Deursen D, Jansz AR, Ott A, van Hellemond JJ, van der Giessen J, Kortbeek LM, Opsteegh M. Friesema IHM, et al. Among authors: van der giessen j. Epidemiol Infect. 2023 May 24;151:e95. doi: 10.1017/S0950268823000808. Epidemiol Infect. 2023. PMID: 37222136 Free PMC article.
Time Scales of Human Mpox Transmission in The Netherlands.
Miura F, Backer JA, van Rijckevorsel G, Bavalia R, Raven S, Petrignani M, Ainslie KEC, Wallinga J; Dutch Mpox Response Team. Miura F, et al. J Infect Dis. 2024 Mar 14;229(3):800-804. doi: 10.1093/infdis/jiad091. J Infect Dis. 2024. PMID: 37014716 Free PMC article.
Mpox outbreak in the Netherlands, 2022: public health response, characteristics of the first 1,000 cases and protection of the first-generation smallpox vaccine.
van Ewijk CE, Miura F, van Rijckevorsel G, de Vries HJ, Welkers MR, van den Berg OE, Friesema IH, van den Berg PR, Dalhuisen T, Wallinga J, Brandwagt D, van Cleef BA, Vennema H, Voordouw B, Koopmans M, van der Eijk AA, Swaan CM, Te Wierik MJ, Leenstra T, Op de Coul E, Franz E; Dutch Mpox Response Team; Members of the Dutch Mpox Response Team. van Ewijk CE, et al. Euro Surveill. 2023 Mar;28(12):2200772. doi: 10.2807/1560-7917.ES.2023.28.12.2200772. Euro Surveill. 2023. PMID: 36951783 Free PMC article.
199 results